ENO1 and pancreatic neoplasm: However, the co-lethality paradigm applies specifically to pancreatic cancer cells, as simultaneous inhibition of ENO1 and GLS did not synergize in inhibiting MDA-MB-231 or NCI-H441 breast and lung cancer cell survival.